Ltr Pharma Fpo has released a press release.
LTR Signs Collaborative Agreement to Develop OMD Nasal Spray
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from LTR Pharma
- Investor Presentation
- Commercial Update and Regulatory Progress
- LTR Pharma to Showcase SPONTAN Data at Urology Conference
- LTR Signs Symbion National Pharmacy Distribution Agreement
- Response to ASX Query Letters
Later from LTR Pharma
- SPONTAN Expands Patient Access via National Pharmacy Network
- Urological Expert Appointed to LTR Scientific Advisory Board
- LTP Completes Extractables Study Milestone for SPONTAN
- SPONTAN 5x Faster Onset Validated in EU Journal
- 18-Month Shelf Life Strengthens SPONTAN Commercialisation
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma